Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Megan Sniecinski currently holds 28,530 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Megan Sniecinski has been a net buyer of BCRX stock. They have purchased $65.3K and sold $0 worth of shares.
Megan Sniecinski's most recent insider trade was on Jan 12, 2026, when they sold 885 shares at $275.74 per share.
Megan Sniecinski serves as Executive at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 5 insider transactions totaling $65.3K over their tenure at the company.
Megan Sniecinski holds the position of Executive at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Megan Sniecinski has shown a buying trading pattern, with $65.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Megan Sniecinski was on Jan 10, 2026, when they sold $313.5K worth of PRAX shares. This transaction involved 1,087 shares at $288.45 per share.
Megan Sniecinski currently owns 28,530 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Megan Sniecinski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Megan Sniecinski has 5 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for Megan Sniecinski and 40,000+ other insiders.